PMH29 COST-CONSEQUENCE ANALYSIS OF ARIPIPRAZOLE IN SCHIZOPHRENIA IN SPAIN: DIABETES AND CORONARY HEART DISEASE PROJECTIONS (STAR STUDY) | Publicación